CFTR: Cystic fibrosis transmembrane conductance regulator
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Epithelial ion channel that plays an important role in the regulation of epithelial ion and water transport and fluid homeostasis.
- Drugs that act on it: 12
- With a US drug page: 2
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Crofelemer | Approved | Cystic fibrosis transmembrane conductance regulator inhibitor | Inhibitor | — |
| Ivacaftor | Approved | Cystic fibrosis transmembrane conductance regulator positive modulator | Positive modulator | — |
| Bamocaftor | — | Cystic fibrosis transmembrane conductance regulator positive modulator | Positive modulator | — |
| Elexacaftor | — | Cystic fibrosis transmembrane conductance regulator positive modulator | Positive modulator | — |
| Galicaftor | — | Cystic fibrosis transmembrane conductance regulator positive modulator | Positive modulator | — |
| Icenticaftor | — | Cystic fibrosis transmembrane conductance regulator activator | Activator | — |
| IOWH-032 | — | Cystic fibrosis transmembrane conductance regulator inhibitor | Inhibitor | — |
| Lumacaftor | — | Cystic fibrosis transmembrane conductance regulator stabiliser | Stabiliser | — |
| Navocaftor | — | Cystic fibrosis transmembrane conductance regulator positive modulator | Positive modulator | — |
| Olacaftor | — | Cystic fibrosis transmembrane conductance regulator positive modulator | Positive modulator | — |
| Tezacaftor | — | Cystic fibrosis transmembrane conductance regulator positive modulator | Positive modulator | — |
| Vanzacaftor | — | Cystic fibrosis transmembrane conductance regulator positive modulator | Positive modulator | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Cystic fibrosis
- 0.92
- Congenital bilateral aplasia of vas deferens from CFTR mutation
- 0.82
- Hereditary chronic pancreatitis
- 0.72
- Bronchiectasis with or without elevated sweat chloride 1
- 0.70
- Congenital bilateral absence of vas deferens
- 0.60
- Bronchiectasis
- 0.58
- CFTR-related disorder
- 0.58
- Diarrheal disease
- 0.54
- Obstructive azoospermia
- 0.54
- Cholestasis
- 0.47
- Respiratory system disorder
- 0.46
Drugs and mechanisms are from ChEMBL CHEMBL4051 (CC BY-SA 3.0). Gene name, function (UniProt P13569, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets